14
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Tuberculosis control in remote districts of Nepal comparing patient-responsible short-course chemotherapy with long-course treatment.

      The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
      Administration, Oral, Antitubercular Agents, administration & dosage, Cohort Studies, Drug Administration Schedule, Humans, Injections, Nepal, Patient Compliance, Prospective Studies, Rifampin, Rural Health Services, Self Administration, Streptomycin, Treatment Outcome, Tuberculosis, Pulmonary, drug therapy

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          A tuberculosis programme in hill and mountain districts of Nepal supported by an international non-governmental organisation (NGO). To evaluate under programme conditions the effectiveness of unsupervised monthly-monitored treatment using an oral short-course regimen. In this prospective cohort study, outcomes for new cases of smear-positive tuberculosis starting treatment over a two-year period in four districts in which a 6-month rifampicin-containing regimen was introduced as first-line treatment (subjects) were compared to outcomes for similarly defined cases in four districts where a 12-month regimen with daily streptomycin injections in the intensive phase continued to be used (controls). Of 359 subjects started on the 6-month regimen, 85.2% completed an initial course of treatment compared to 62.8% of 304 controls started on the 12-month regimen (P < 0.001); 78.8% of subjects and 51.0% of controls were confirmed smear-negative at the end of treatment (P < 0.001). The case-fatality rate during treatment was 5.0% among subjects and 11.2% among controls (P = 0.003). Among those whose status was known at two years, 76.9% of subjects were smear-negative without retreatment, compared to 60.9% of controls (P < 0.001). In an NGO-supported tuberculosis control programme in remote districts of Nepal, patient-responsible short-course therapy supported by rapid tracing of defaulters achieved acceptable outcomes. Where access and health care infrastructure are poor, district-level tuberculosis teams responsible for treatment planning, drug delivery and programme monitoring can be an appropriate service model.

          Related collections

          Author and article information

          Comments

          Comment on this article